Corrigendum to “Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized active-controlled trial” [Vaccine 40(19) (2022) 2705–2713]

Detalles Bibliográficos
Autores principales: Crothers, Jessica W., Ross Colgate, Elizabeth, Cowan, Kelly J., Dickson, Dorothy M., Walsh, MaryClaire, Carmolli, Marya, Wright, Peter F., Norton, Elizabeth B., Kirkpatrick, Beth D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2022
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168436/
https://www.ncbi.nlm.nih.gov/pubmed/35534312
http://dx.doi.org/10.1016/j.vaccine.2022.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168436/
https://www.ncbi.nlm.nih.gov/pubmed/35534312
http://dx.doi.org/10.1016/j.vaccine.2022.05.001

Ejemplares similares